Another preclinical study evaluating allogeneic cells identified CD70 CAR-T binding epitopes that exhibited important antitumor activity against RCC cell lines and in a xenograft mouse model of RCC derived from patients [31]. Here, CD70 is linked to renal cell carcinoma.